A phase Ib dose-escalation study of binimetinib (MEK162) in combination with weekly paclitaxel in patients with platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer Meeting Abstract
| Authors: | Grisham, R. N.; Gordon, M. S.; Harb, W. A.; Aghajanian, C.; McMeekin, D. S.; McKinley, K.; Anderson, L. R.; Chavira, R.; Christy-Bittel, J.; Barrett, E.; Moore, K. N. |
| Abstract Title: | A phase Ib dose-escalation study of binimetinib (MEK162) in combination with weekly paclitaxel in patients with platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036901175 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.15_suppl.5516 |
| Notes: | Meeting Abstract: 5516 -- Source: Wos |
